• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.一类 HCV 广谱中和抗体及其前体的免疫遗传学和结构分析。
Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):7569-7574. doi: 10.1073/pnas.1802378115. Epub 2018 Jun 28.
2
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.来自与Fc IgG融合的前体蛋白的重组gpE1/gpE2异源二聚体疫苗抗原的天然折叠
J Virol. 2016 Dec 16;91(1). doi: 10.1128/JVI.01552-16. Print 2017 Jan 1.
3
Broadly Neutralizing Antibodies Targeting New Sites of Vulnerability in Hepatitis C Virus E1E2.广谱中和抗体靶向丙型肝炎病毒 E1E2 新弱点。
J Virol. 2019 Jun 28;93(14). doi: 10.1128/JVI.02070-18. Print 2019 Jul 15.
4
A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance.用于疫苗研究的多种丙型肝炎病毒糖蛋白组合揭示了单克隆抗体中和抗性的极端情况。
J Virol. 2015 Dec 23;90(7):3288-301. doi: 10.1128/JVI.02700-15.
5
HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design.HCV 广泛中和抗体利用 CDRH3 二硫键基序识别 E2 糖蛋白位点，该位点可作为疫苗设计的靶标。
Cell Host Microbe. 2018 Nov 14;24(5):703-716.e3. doi: 10.1016/j.chom.2018.10.009.
6
Antibody Responses to Immunization With HCV Envelope Glycoproteins as a Baseline for B-Cell-Based Vaccine Development.免疫 HCV 包膜糖蛋白的抗体反应作为基于 B 细胞的疫苗开发的基础。
Gastroenterology. 2020 Mar;158(4):1058-1071.e6. doi: 10.1053/j.gastro.2019.11.282. Epub 2019 Dec 4.
7
Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice.糖基化模式的改变增强了一种丙型肝炎病毒亚单位疫苗的免疫原性，诱导产生的中和抗体可在小鼠中提供保护。
J Virol. 2016 Nov 14;90(23):10486-10498. doi: 10.1128/JVI.01462-16. Print 2016 Dec 1.
8
Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes.丙型肝炎病毒逃避表位 I 中和作用增加了其他中和表位的敏感性。
J Virol. 2018 Apr 13;92(9). doi: 10.1128/JVI.02066-17. Print 2018 May 1.
9
Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region.针对丙型肝炎病毒糖蛋白E2的单克隆抗体可检测到由N端高变区1（HVR1）、HVR2和基因间可变区调节的抗原差异。
J Virol. 2015 Dec;89(24):12245-61. doi: 10.1128/JVI.02070-15. Epub 2015 Sep 16.
10
Fine mapping of murine antibody responses to immunization with a novel soluble form of hepatitis C virus envelope glycoprotein complex.对新型可溶性丙型肝炎病毒包膜糖蛋白复合物免疫接种的小鼠抗体反应进行精细定位。
J Virol. 2014 Sep;88(18):10459-71. doi: 10.1128/JVI.01584-14. Epub 2014 Jun 25.

引用本文的文献

1
Cryo-EM structures of HCV E2 glycoprotein bound to neutralizing and non-neutralizing antibodies determined using bivalent Fabs as fiducial markers.利用二价Fab片段作为基准标记物测定的丙型肝炎病毒E2糖蛋白与中和及非中和抗体结合的冷冻电镜结构。
Commun Biol. 2025 May 29;8(1):825. doi: 10.1038/s42003-025-08239-w.
2
Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development.丙型肝炎病毒 E1E2 结构、多样性及其对疫苗开发的影响。
Viruses. 2024 May 18;16(5):803. doi: 10.3390/v16050803.
3
Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies.工程化丙型肝炎病毒 E1E2 外域结构与其中和抗体复合物。
Nat Commun. 2023 Jul 5;14(1):3980. doi: 10.1038/s41467-023-39659-z.
4
Effect of Glycan Shift on Antibodies against Hepatitis C Virus E2 412-425 Epitope Elicited by Chimeric sHBsAg-Based Virus-Like Particles.聚糖变化对基于嵌合乙型肝炎表面抗原的病毒样颗粒引发的抗丙型肝炎病毒E2 412-425表位抗体的影响。
Microbiol Spectr. 2023 Jan 31;11(2):e0254622. doi: 10.1128/spectrum.02546-22.
5
Structural and Biophysical Characterization of the HCV E1E2 Heterodimer for Vaccine Development.HCV E1E2 异二聚体的结构和生物物理特征及其在疫苗开发中的应用。
Viruses. 2021 May 29;13(6):1027. doi: 10.3390/v13061027.
6
From Structural Studies to HCV Vaccine Design.从结构研究到丙型肝炎病毒疫苗设计。
Viruses. 2021 May 4;13(5):833. doi: 10.3390/v13050833.
7
Evaluation of a Series of Lipidated Tucaresol Adjuvants in a Hepatitis C Virus Vaccine Model.在丙型肝炎病毒疫苗模型中对一系列脂化土卡索醇佐剂的评估。
ACS Med Chem Lett. 2020 Oct 29;11(12):2428-2432. doi: 10.1021/acsmedchemlett.0c00413. eCollection 2020 Dec 10.
8
Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms.亚铁转运蛋白结合血红素肽的结构揭示了铁稳态的机制。
Nature. 2020 Oct;586(7831):807-811. doi: 10.1038/s41586-020-2668-z. Epub 2020 Aug 19.
9
Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency.用携带丙型肝炎病毒包膜糖蛋白2表位的乙型肝炎病毒样颗粒免疫诱导产生的特异性抗体表现出不同的中和效率。
Vaccines (Basel). 2020 Jun 10;8(2):294. doi: 10.3390/vaccines8020294.
10
Antibody Responses in Hepatitis C Infection.丙型肝炎感染中的抗体反应。
Cold Spring Harb Perspect Med. 2021 Mar 1;11(3):a036962. doi: 10.1101/cshperspect.a036962.

本文引用的文献

1
Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis.高通量突变探测丙型肝炎病毒包膜糖蛋白复合物的抗原性。
PLoS Pathog. 2017 Dec 18;13(12):e1006735. doi: 10.1371/journal.ppat.1006735. eCollection 2017 Dec.
2
Structure-Based Design of Hepatitis C Virus Vaccines That Elicit Neutralizing Antibody Responses to a Conserved Epitope.引发针对保守表位的中和抗体反应的丙型肝炎病毒疫苗的基于结构的设计
J Virol. 2017 Sep 27;91(20). doi: 10.1128/JVI.01032-17. Print 2017 Oct 15.
3
Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen.丙型肝炎病毒E2抗原上一个主要保守抗体靶点的结构灵活性。
Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):12768-12773. doi: 10.1073/pnas.1609780113. Epub 2016 Oct 24.
4
Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication-competent virus and pseudoparticles.使用具有复制能力的病毒和假病毒颗粒测定丙型肝炎病毒对广泛中和抗体的抗性。
J Gen Virol. 2016 Nov;97(11):2883-2893. doi: 10.1099/jgv.0.000608. Epub 2016 Sep 21.
5
Viral evasion and challenges of hepatitis C virus vaccine development.丙型肝炎病毒疫苗研发中的病毒逃逸及挑战
Curr Opin Virol. 2016 Oct;20:55-63. doi: 10.1016/j.coviro.2016.09.004. Epub 2016 Sep 19.
6
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies.旨在靶向聚糖依赖性广泛中和抗体种系前体的HIV疫苗设计。
Immunity. 2016 Sep 20;45(3):483-496. doi: 10.1016/j.immuni.2016.08.016. Epub 2016 Sep 8.
7
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires.在具有不同前体库的小鼠中诱导HIV中和抗体谱系
Cell. 2016 Sep 8;166(6):1471-1484.e18. doi: 10.1016/j.cell.2016.07.029.
8
Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies.诱导保护性中和抗体的丙型肝炎病毒候选疫苗
Expert Rev Vaccines. 2016 Dec;15(12):1535-1544. doi: 10.1080/14760584.2016.1194759. Epub 2016 Jun 13.
9
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.通过靶向胚系免疫原揭示的HIV-1广泛中和抗体前体B细胞
Science. 2016 Mar 25;351(6280):1458-63. doi: 10.1126/science.aad9195.
10
Structural basis for germline antibody recognition of HIV-1 immunogens.生殖系抗体识别HIV-1免疫原的结构基础。
Elife. 2016 Mar 21;5:e13783. doi: 10.7554/eLife.13783.

一类 HCV 广谱中和抗体及其前体的免疫遗传学和结构分析。

Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.

机构信息

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037.

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.

出版信息

Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):7569-7574. doi: 10.1073/pnas.1802378115. Epub 2018 Jun 28.

DOI:10.1073/pnas.1802378115
PMID:29954862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6055136/
Abstract

Elicitation of broadly neutralizing antibodies (bnAbs) is a leading strategy in rational vaccine design against antigenically diverse pathogens. Here, we studied a panel of monoclonal antibodies (mAbs) from mice immunized with the hepatitis C virus (HCV) envelope glycoproteins E1E2. Six of the mAbs recognize the conserved E2 antigenic site 412-423 (AS412) and cross-neutralize diverse HCV genotypes. Immunogenetic and structural analysis revealed that the antibodies originated from two different germline (GL) precursors and bind AS412 in a β-hairpin conformation. Intriguingly, the anti-HCV activity of one antibody lineage is associated with maturation of the light chain (LC), whereas the other lineage is dependent on heavy-chain (HC) maturation. Crystal structures of GL precursors of the LC-dependent lineage in complex with AS412 offer critical insights into the maturation process of bnAbs to HCV, providing a scientific foundation for utilizing the mouse model to study AS412-targeting vaccine candidates.

摘要

诱导广谱中和抗体 (bnAbs) 是针对具有不同抗原性的病原体进行合理疫苗设计的主要策略。在这里，我们研究了一组用丙型肝炎病毒 (HCV) 包膜糖蛋白 E1E2 免疫的小鼠产生的单克隆抗体 (mAb)。其中 6 种 mAb 识别保守的 E2 抗原表位 412-423 (AS412)，并交叉中和多种 HCV 基因型。免疫遗传和结构分析表明，这些抗体来源于两个不同的胚系 (GL) 前体，并以 β 发夹构象结合 AS412。有趣的是，一种抗体谱系的抗 HCV 活性与轻链 (LC) 的成熟有关，而另一种谱系则依赖于重链 (HC) 的成熟。与 AS412 结合的 LC 依赖性谱系 GL 前体的晶体结构提供了对 HCV bnAbs 成熟过程的重要见解，为利用小鼠模型研究 AS412 靶向疫苗候选物提供了科学基础。